Monday, February 3, 2014

Opexa Therapeutics, Inc. (OPXA) Video Chart for Friday, January 31, 2014

OPXA is once again holding a support level at $1.65 as the chart looks to be making a large rounded bottom. The indicators are still neutral, but they are giving early signs that the support will hold as the chart tries to again break above the 50-day and 200-day moving averages towards some resistance at $2.00.

To view the video chart, visit the following link: http://www.missionir.com/videos.html

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com


Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Advaxis, Inc. (ADXS) Presenting at the 16th Annual BIO CEO & Investor Conference

Today before the opening bell, Advaxis announced that it will be presenting at the 16th Annual BIO CEO & Investor Conference at the Waldorf Astoria in New York City in mid-February. Mr. Daniel J. O’Connor, Chief Executive Officer of Advaxis, will be presenting a company update at the conference on Tuesday, February 11, 2014 at 3:30 pm EST.

Those who wish to see the presentation are advised to visit the following link for a live webcast: http://www.veracast.com/webcasts/bio/ceoinvestor2014/08238316629.cfm.

Advaxis is a clinical-stage biotechnology company developing the next generation of cancer immunotherapies. Advaxis’ immunotherapies are based on a novel platform technology using live, attenuated bacteria to stimulate the immune system to selectively target cancer cells while reducing tumor defenses.

For more information, visit: www.advaxis.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com


Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

CytRx Corp. (CYTR) Presenting at the 16th Annual BIO CEO & Investor Conference

CytRx today released a news release stating it will be presenting at the 16th Annual BIO CEO & Investor Conference next week at the Waldorf Astoria in New York City. CytRx’s President and CEO, Steven A. Kriegsman, as well as Vice President of Business Development, David Haen, will be presenting a corporate update on Monday, February 10, 2014 at 2:30 pm EST (11:30 am PST).

Among other things, the company will be covering its expanded 2014 aldoxorubicin development pipeline after its recent successful $75 million financing. Onlookers are advised to visit the company’s Investors section, at: www.cytrx.com/investors/presentations.

CytRx is a biopharmaceutical research and development company specializing in oncology. CytRx currently is focused on the clinical development of aldoxorubicin (formerly known as INNO-206), its improved version of the widely used chemotherapeutic agent doxorubicin.

For more information, visit: www.cytrx.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com


Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

ForeverGreeen Worldwide Corp. (FVRG) Adds Record Number of Industry Leaders in January

2014 has already been a big year for ForeverGreen Worldwide Corporation, who has announced that over forty seasoned industry leaders have joined the company in four short weeks.

Company CEO Ron Williams remarked, “ForeverGreen is engaging in amazing leadership events that are bringing new established leaders to the company on a regular basis. These leaders have generated hundreds of millions of dollars in annual revenue at companies with which they were previously involved. With the addition of these leaders, it is expected that the company will exceed our previously announced goals for 2014.”

ForeverGreen develops, manufactures, and distributes an expansive line of all natural whole foods and products to North America, Australia, Europe, Asia, and South America. Their products include whole-food beverages Azul and FrequenSea™, a Versative line of hemp-based food products, immune support supplements, weight management products, and more. The company also has an entire catalog of meals, snacks, household cleaners, and personal care products.

The company’s newest global offering is PowerStrips. You can learn more about that, as well as all its other products, at www.forevergreen.org.

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com


Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Weatherford International Ltd. (WFT): Growing Global Oil Demand will Ensure Long-Term Growth

Weatherford International is an oil field service provider that is planning to capitalize on the increasing engagement of drilling and completion activity by the oil-producing companies in order to meet the growing global oil demand. Additionally, the crude oil price is also improving, which in turn spurs oil producers to increase production. Generally, the increase in production could be through drilling new wells and using different technical advancements in existing wells to ensure stable production. The oil producers and explorers are focusing on improving production techniques and are expected to spend more in the coming years. Technical advancements like efficient drilling, casing, pressure pumping, and artificial lifting are the best practices by the oil producers across the world to sustain long-term stable production.

Weatherford offers advanced and wide oil field service products that include drilling service, well construction including casing, artificial lift systems, and well-completion systems. These products are offered individually or bundled together at the oil-production sites. As more drilling in the oil-producing shale is expected in coming years, the company through its operation in more than 100 countries has viable long-term growth prospects.

Weatherford’s artificial lift system will strengthen the top line
Artificial lift systems are primarily used in oil wells to increase the reservoir pressure towards the surface. This technique is useful where the natural pressure under the reservoir is not enough to push oil upside. Thus, the oil-producing companies use artificial lifts to recover the reservoir oil and ensure stable long-term production from the oil producing wells. In the U.S., 96% of the total oil wells require artificial lift techniques. The global market revenue for artificial lift segment will reach $16 billion by 2018 with a compounded annual growth rate (CAGR) of 9.5% from 2013 to 2018. North America has dominated the global market of artificial lifts with 45.5% revenue in 2012. Europe, along with South and Central America, the Middle East, and Africa, is expected to see growth in this market by 2018.

Weatherford is one of the leading providers of artificial lifts and holds one-third of the total domestic artificial lift market. Weatherford’s artificial lift system ensures that the producing company can capture more resources compared to the traditional process. Its artificial lift system helps to reduce the maintenance cost while increasing the well’s production life. The company’s artificial lift system comes under its completion and production segment. This segment contributed 39% of the total revenue during third quarter. The artificial lift system under this segment is the key driver for revenue improvement. As a result, during the third quarter last year, the company’s North American segment revenue improved by 4% with stronger artificial lift results compared to the previous quarter. Although due to increased pricing pressure, it has shown a decline in revenue by 7% compared to 2012. With the projected market revenue growth of this technique internationally, Weatherford should still manage to improve its top line.

Another major player, Schlumberger (SLB), also provides oil field services and equipment to the oil producers. Its production group includes well intervention, completion, and artificial lift systems. As the demand of drilling efficiency among the oil-producing companies is increasing, more improved oil field service techniques are provided by the oil field service providers. This focus on efficiency is likely to create more demand for services like Schlumberger’s HiWAY. This technique is a well-fracturing service used for the extraction of shale oil and gas. This service has increased oil production by 20%. With the growing demand of these products, Schlumberger experienced an 8% improvement in its overall production group segment revenue during the fourth quarter of 2013.

Increasing rig count will be a success factor
50% of Weatherford’s non-core business revenue comes from its land-rig operation. Weatherford has improved upon its consolidated revenue of $1 million during the third quarter. The company’s formation evaluation and well construction segment contributed 61% of the total revenue. It includes drilling, casing, and laboratory services etc., and is considered to be the primary source of Weatherford’s financial performance. This segment’s revenue depends on the company’s working rigs in the oil field and other drilling-related services. Although Weatherford’s total number of rigs in North America has decreased by 4% during third quarter in 2013 due to price related issues, the company’s international rig count has increased at a steady rate. As a result, the international revenues increased by 6% to $129 million compared to the third quarter of 2012.

With growing oil demand, oil-producing companies are seeking more rigs for higher production, which in turn results in more rig counts. North America has witnessed a growth of 23 rigs last week in the U.S. and 88 rigs in Canada. Apart from that, the international rig count has also improved. With Weatherford’s North American operation and with increased drilling activity in the Eastern hemisphere, the company is expected to witness a strong improvement in its formation evaluation and well-construction revenue.

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com


Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Galena Biopharma, Inc. (GALE) Pipeline Products Include Immunotherapy Cancer Treatments

Galena Biopharma is focused on discovering, developing, and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics.

Abstral, the Company’s sublingual formulation of fentanyl citrate, provides statistically significant and rapid relief of breakthrough cancer pain for patients with all types of cancer, providing improvements in pain-related daily function and patient quality of life. Currently in clinical trials, though, is NeuVax (neliepimut-S or E75), one of Galena’s cancer immunotherapy treatments.

The immunotherapy of cancer aims at specifically activating cells of the immune system, especially the so-called cytotoxic T-cells (“killer T-cells”) to seek out and eliminate tumor cells while not harming healthy tissue.

NeuVax works by turning on the immune system. It recruits the main components of the cellular immune system to fight cancer by presentation of a T-cell peptide epitope in the context of the peptide-HLA-T-cell receptor complex–effectively using the patient’s own immune system (i.e., nature’s own defense system against foreign or harmful germs) for the treatment of the cancer.

Folate Binding Protein-E39 (FBP), another Galena treatment, is a targeted vaccine aimed at preventing the recurrence of ovarian, endometrial, and breast cancers. It has very limited tissue distribution and expression in non-malignant tissue making it an ideal immunotherapy target.

The FBP vaccine consists of the E39 peptide derived from the folate binding protein combined with the immune adjuvant granulocyte macrophage colony stimulating factor (GM-CSF), and is specifically used to treat endometrial and ovarian cancers.

Ideally, a vaccine is specific and should only affect the cancer cells and not attack normal cells. Cancer immunotherapy causes the immune system to make antibodies to one or several specific antigens, and/or make killer T cells to attack cancer cells that express those antigens. Similar to prophylactic vaccines, Galena’s cancer immunotherapies can be delivered with adjuvants, which are designed to boost the immune response.

For more information, visit the website at www.galenabiopharma.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com


Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Chanticleer Holdings, Inc. (HOTR) Expands Portfolio, Acquires Hooters Pacific Northwest Franchise

Chanticleer Holdings, Inc. (HOTR) Expands Portfolio, Acquires Hooters Pacific Northwest Franchise

Chanticleer Holdings, a minority holder in the privately held parent company of the Hooters® brand Hooters Of America and a franchisee of international Hooters restaurants, has completed its acquisition of Hooters U.S. Pacific Northwest franchise rights and two existing restaurants in Oregon and Washington.

Chanticleer has acquired 100 percent of the shares of Tacoma Wings, LLC and Hooters of Oregon Partners, LLC, owners and operators of the two locations in Portland, Ore., and Tacoma, Wash. Per the agreement, Chanticleer has obtained all leasehold and current franchise rights to the Hooters locations in Oregon and Washington. As part of its ongoing effort to expand its portfolio, Chanticleer management is also evaluating locations around the Portland and Seattle areas for future restaurant openings.

In addition, Chanticleer reports that it has acquired Chef John Tesar’s fine dining seafood restaurant, Spoon Bar & Kitchen, located in Dallas, Texas. Chanticleer intends to expand the Spoon brand by stretching its healthier seafood menu into a new, fast-casual dining concept.

“We are starting off the new year successfully completing both of these acquisitions and more importantly adding three operating restaurants to our portfolio. The Pacific Northwest provides strategic opportunities to expand the footprint of our brands,” Chanticleer chairman and CEO Mike Pruitt stated in the news release.

Chanticleer also owns and operates American Roadside Burgers and owns a majority interest in Just Fresh restaurants in the United States.

For more information, visit www.chanticleerholdings.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com


Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html